Literature DB >> 34140036

Circ-SPG11 knockdown hampers IL-1β-induced osteoarthritis progression via targeting miR-337-3p/ADAMTS5.

Yongqiang Liu1, Qian Li1, Zhida Gao1, Fang Lei2, Xuefeng Gao1.   

Abstract

BACKGROUND: Osteoarthritis (OA) is responsible for the impotent disability in old people. Circular RNA (circRNA) has been reported to be related to the development of diseases. The lack of research on the role of circRNA spastic paraplegia 11 (circ-SPG11) results in conducting this study.
METHODS: The expression of circ-SPG11, microRNA-337-3p (miR-337-3p), and aggrecanases like a disintegrin and metalloproteinase with thrombospondin motifs 5 (ADAMTS5) mRNA was detected by quantitative real-time polymerase chain reaction (qRT-PCR). Western blot was used to measure the protein expression of extracellular matrix (ECM) degradation-related markers and ADAMTS5. Ribonuclease R (RNase R) was applied to test the stability of circ-SPG11 in CHON-001 cells. The viability, apoptosis, TNF-α and IL-6 production were determined by cell counting kit-8 (CCK-8) assay, flow cytometry assay, and enzyme-linked immunosorbent assay (ELISA), respectively. Meanwhile, the interaction between miR-337-3p and circ-SPG11 or ADAMTS5 was respectively predicted by Circinteractome or Starbase2.0, which was further verified by dual-luciferase reporter system and RNA binding protein immunoprecipitation (RIP) assay.
RESULTS: Circ-SPG11 and ADAMTS5 were upregulated and miR-337-3p was downregulated in OA tissues and OA model cells. Circ-SPG11 knockdown allayed interleukin 1β (IL-1β)-induced restraint in viability and promotion in apoptosis, TNF-α, and IL-6 generation and ECM degradation in CHON-001 cells. Anti-miR-337-3p or ADAMTS5 overexpression correspondingly reversed si-circ-SPG11 or miR-337-3p overexpression-mediated facilitation in viability, and inhibition in apoptosis, TNF-α and IL-6 generation and ECM degradation in OA model cells. Moreover, anti-miR-337-3p ameliorated si-circ-SPG11-mediated inhibition in ADAMTS5 mRNA and protein expression in OA model cells.
CONCLUSION: Circ-SPG11 facilitated OA development via regulating miR-337-3p/ADAMTS5 axis. This finding might contribute to the improvement of OA therapy.

Entities:  

Keywords:  ADAMTS5; Circ-SPG11; IL-1β; MiR-337-3p; Osteoarthritis

Year:  2021        PMID: 34140036     DOI: 10.1186/s13018-021-02526-y

Source DB:  PubMed          Journal:  J Orthop Surg Res        ISSN: 1749-799X            Impact factor:   2.359


  23 in total

1.  Circular RNA-9119 protects IL-1β-treated chondrocytes from apoptosis in an osteoarthritis cell model by intercepting the microRNA-26a/PTEN axis.

Authors:  Changjian Chen; Peng Yin; Shengxiong Hu; Xuegang Sun; Baowen Li
Journal:  Life Sci       Date:  2020-06-07       Impact factor: 5.037

2.  CircRNA-UBE2G1 regulates LPS-induced osteoarthritis through miR-373/HIF-1a axis.

Authors:  Guang Chen; Tao Liu; Bofan Yu; Bingyi Wang; Qiang Peng
Journal:  Cell Cycle       Date:  2020-05-31       Impact factor: 4.534

3.  Circular RNA Atp9b, a competing endogenous RNA, regulates the progression of osteoarthritis by targeting miR-138-5p.

Authors:  Zhi-Bin Zhou; Di Du; Gao-Xiang Huang; Aimin Chen; Lei Zhu
Journal:  Gene       Date:  2018-01-03       Impact factor: 3.688

Review 4.  Circular RNA: A new star of noncoding RNAs.

Authors:  Shibin Qu; Xisheng Yang; Xiaolei Li; Jianlin Wang; Yuan Gao; Runze Shang; Wei Sun; Kefeng Dou; Haimin Li
Journal:  Cancer Lett       Date:  2015-06-05       Impact factor: 8.679

Review 5.  Ageing and the pathogenesis of osteoarthritis.

Authors:  Richard F Loeser; John A Collins; Brian O Diekman
Journal:  Nat Rev Rheumatol       Date:  2016-05-19       Impact factor: 20.543

6.  Circ_0076305 regulates cisplatin resistance of non-small cell lung cancer via positively modulating STAT3 by sponging miR-296-5p.

Authors:  Yu Dong; Tao Xu; Shouping Zhong; Bo Wang; Huimin Zhang; Xin Wang; Peng Wang; Guangshun Li; Shuanying Yang
Journal:  Life Sci       Date:  2019-10-21       Impact factor: 5.037

7.  Incidence and risk factors for clinically diagnosed knee, hip and hand osteoarthritis: influences of age, gender and osteoarthritis affecting other joints.

Authors:  Daniel Prieto-Alhambra; Andrew Judge; M Kassim Javaid; Cyrus Cooper; Adolfo Diez-Perez; Nigel K Arden
Journal:  Ann Rheum Dis       Date:  2013-06-06       Impact factor: 19.103

8.  Circular RNA TTBK2 regulates cell proliferation, invasion and ferroptosis via miR-761/ITGB8 axis in glioma.

Authors:  H-Y Zhang; B-W Zhang; Z-B Zhang; Q-J Deng
Journal:  Eur Rev Med Pharmacol Sci       Date:  2020-03       Impact factor: 3.507

9.  Health economics in the field of osteoarthritis: an expert's consensus paper from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO).

Authors:  Mickaël Hiligsmann; Cyrus Cooper; Nigel Arden; Maarten Boers; Jaime C Branco; Maria Luisa Brandi; Olivier Bruyère; Francis Guillemin; Marc C Hochberg; David J Hunter; John A Kanis; Tore K Kvien; Andrea Laslop; Jean-Pierre Pelletier; Daniel Pinto; Susanne Reiter-Niesert; René Rizzoli; Lucio C Rovati; Johan L Hans Severens; Stuart Silverman; Yannis Tsouderos; Peter Tugwell; Jean-Yves Reginster
Journal:  Semin Arthritis Rheum       Date:  2013-08-29       Impact factor: 5.532

10.  CircSERPINE2 protects against osteoarthritis by targeting miR-1271 and ETS-related gene.

Authors:  Shuying Shen; Yizheng Wu; Junxin Chen; Ziang Xie; Kangmao Huang; Gangliang Wang; Yute Yang; Weiyu Ni; Zhijun Chen; Peihua Shi; Yan Ma; Shunwu Fan
Journal:  Ann Rheum Dis       Date:  2019-03-28       Impact factor: 19.103

View more
  2 in total

Review 1.  Crosstalk Among circRNA/lncRNA, miRNA, and mRNA in Osteoarthritis.

Authors:  Hui Kong; Ming-Li Sun; Xin-An Zhang; Xue-Qiang Wang
Journal:  Front Cell Dev Biol       Date:  2021-12-15

2.  Circular RNA circ_0008365 regulates SOX9 by targeting miR-338-3p to inhibit IL-1β-induced chondrocyte apoptosis and extracellular matrix degradation.

Authors:  Shengbin Shuai; Qianqian Cai; Yunxia Ou
Journal:  J Orthop Surg Res       Date:  2022-10-14       Impact factor: 2.677

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.